Status:

NOT_YET_RECRUITING

Clinical Trial on the Accuracy of Blood Pressure Measurement by YE990 Medical Automatic Electronic Sphygmomanometer

Lead Sponsor:

The First Affiliated Hospital of Anhui Medical University

Conditions:

Blood Pressure

Eligibility:

All Genders

12+ years

Brief Summary

This study was a single-center, open-ended, self-controlled clinical study . Same armsequential method was used to measure the blood pressure of the subjects,inclusion of ≥85 subjects aged 12 years or...

Detailed Description

This study was a single-center, open-ended, self-controlled clinical study . Same armsequential method was used to measure the blood pressure of the subjects,inclusion of ≥85 subjects aged 12 years or...

Eligibility Criteria

Inclusion

  • Subjects should meet all of the following requirements for inclusion in the study:
  • Both sexes; at least 30% of the subjects are male and at least 30% of the subjects are female.
  • Subject's age \> 12 years.
  • Arm circumference distribution:
  • At least 20% of the subjects should have arm circumference within each quarter interval of the total arm circumference range;
  • At least 10% of the subjects should have arm circumference within the upper one-eighth interval of the total arm circumference range;
  • At least 10% of the subjects shall have an arm circumference within the lower one-eighth interval of the total arm circumference range.
  • Blood pressure distribution:
  • At least 5% of subjects shall have a systolic blood pressure ≤100 mmHg (13.33 kPa);
  • At least 5% of subjects shall have a systolic blood pressure ≥ 160 mmHg (21.33 kPa);
  • At least 20% of subjects should have a systolic blood pressure ≥ 140 mmHg (18.66 kPa);
  • Diastolic blood pressure should be ≤60 mmHg (8.0 kPa) in at least 5% of subjects;
  • Diastolic blood pressure should be ≥100 mmHg (13.33 kPa) in at least 5% of subjects; (f) At least 20% of subjects should have a diastolic blood pressure ≥85 mmHg (11.33 kPa);
  • Subjects must be willing and able to comply with the study procedures by signing an informed consent form after being informed about the study.
  • consent form after understanding the contents of the study.
  • Good compliance and ability to complete the clinical trial.

Exclusion

  • Subjects who fulfill any of the following requirements cannot be included in the study:
  • (1) Mental illness, impaired consciousness, or other conditions that prevent them from cooperating with the study; (2) Require hemodialysis; (3) Taking anticoagulant drugs for cardiovascular diseases; (4) Pregnant and lactating women; (5) Patients with cardiac arrhythmia; (6) Patients with peripheral arterial disease and diseases that may affect arterial compliance; (7) Other conditions that are considered by the physician to be unsuitable for enrollment.
  • \-

Key Trial Info

Start Date :

August 20 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 30 2025

Estimated Enrollment :

85 Patients enrolled

Trial Details

Trial ID

NCT06565702

Start Date

August 20 2024

End Date

December 30 2025

Last Update

August 22 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Affiliated Hospital of Anhui Medical University Hospital

Hefei, Anhui, China, 230000